title: Splenic infarction after N-butyl-2-cyanoacrylate injection for gastric varices: why does it happen?
abstract: Recent guidelines and consensus reports recommend endoscopic injection therapy with N-butyl-2-cyanoacrylate as the first-line treatment for bleeding-isolated gastric varices and gastroesophageal varices types 1 and 2. Embolization is a rare but serious complication of cyanoacrylate injection, which may be fatal in some cases. Herein, we present a patient who developed splenic infarction after N-butyl-cyanoacrylate injection for gastroesophageal varices type 2 and discuss the potential reasons and tips to prevent the occurence of embolization.
authors.affiliation: Departments of *Gastroenterology †Radiology, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey.
authors.forename: Aydin S
authors.initials: AS
authors.lastname: Köksal
authors.forename: Ertuğrul
authors.initials: E
authors.lastname: Kayaçetin
authors.forename: Serkan
authors.initials: S
authors.lastname: Torun
authors.forename: Vedat
authors.initials: V
authors.lastname: Erkan
authors.forename: Riza S
authors.initials: RS
authors.lastname: Ökten
mesh_terms: D000328:Adult; D004659:Enbucrilate / Q000008:administration & dosage / Q000009:adverse effects*; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D005260:Female; D005773:Gastroscopy / Q000379:methods; D006801:Humans; D015552:Injections, Intralesional; D012597:Sclerosing Solutions / Q000008:administration & dosage / Q000009:adverse effects*; D013159:Splenic Infarction / Q000139:chemically induced*
chemical_list: D012597:Sclerosing Solutions; D004659:Enbucrilate